Vaginal immunity in the HSV-2 mouse model

International Reviews of Immunology

Volumn 22, Issue 1, 2003, Pages 43-63

  Parr, Margaret B ^a   Parr, Earl L ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Herpes simplex virus type 2; Mouse; Mucosal immunity; Vagina

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFECTION RISK; LATENT VIRUS INFECTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; RECURRENT DISEASE; REINFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE ACTIVATION; VAGINA MUCOSA; VASCULAR ENDOTHELIUM;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HERPESVIRUS VACCINES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTES; MICE; MICE, KNOCKOUT; VAGINA;

EID: 0037260615     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180305228     Document Type: Review

References (70)

1. W.E. Rauls, Herpes simplex virus. In B.N. Fields (Ed.) Virology, New York: Raven Press, pp. 529-561, 1985.
2. G.V. Quinnan, H. Masur, A.H. Rook, G. Armstrong, W.R. Frederick, J. Epstein, J.F. Manischewitz, et al., Herpes virus infection in acquired immune deficiency. J. Am. Med. Assoc., 252: 72-77, 1984.
3. R.M. Greenblatt, S.A. Lukehart, F.A. Plummer, T.C. Quinn, C.W. Critchlow, R.L. Ashley, L.J. D'Costa, et al., Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS, 2: 47-50, 1988.
4. R. Whitley, A. Arvin, and C. Prober, Predictors of morbidity and mortality in neonates with herpes simplex virus infection. N. Eng. J. Med., 154: 415-421, 1991.
5. L. Corey and P.G. Spear, Infections with herpes simplex viruses, parts 1 and 2. N. Engl. J. Med., 314: 686-691, 749-757, 1986.
6. L.R. Stanberry, Evaluation of herpes simplex virus vaccines in animals: The guinea pig vaginal model. Rev. Infect. Dis., 13: S920-S923, 1991.
7. M.R. McDermott, B.J. Smiley, P.L.J. Brais, H. Rudzroga, and J. Bienenstock, Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol., 51: 247-253, 1984.
8. M.R. McDermott, P.L.J. Brais, G.C. Goettsche, M.J. Evelegh, and C.H. Goldsmith, Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Arch. Virol., 93: 51-68, 1987.
9. M.R. McDermott, L.J. Brais, and M.J. Evelegh, Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol., 71: 1497-1504, 1990.
10. M.B. Parr, L. Kepple, M.R. McDermott, M.D. Drew, J.J. Bozzola, and E.L. Parr, A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest., 70: 369-380, 1994.
11. M.B. Parr and E.L. Parr, Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol., 72: 2677-2685, 1998.
12. E.L. Parr and M.B. Parr, Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2. J. Virol., 72: 5137-5145, 1998.
13. B. Underdown and J. Shiff, Immunoglobulin A: Strategic defense initiative at the mucosal surface. Ann. Rev. Immunol., 4: 389-417, 1986.
14. B.R. Murphy, Mucosal immunity to viruses. In P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock (Eds.), Handbook of Mucosal Immunology. San Diego: Academic Press, Inc., pp. 333-343, 1994.
15. M. Kilian and M.W. Russell, Function of mucosal immunoglobulins. In P.L. Ogra, M.E. Lamm, J.R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock (Eds.), Handbook of Mucosal Immunology. San Diego: Academic Press, Inc., pp. 127-137, 1994.
16. J.R. McGhee and J. Mestecky, In defense of mucosal surfaces: Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. Infect. Dis. Clin. North. Amer., 4: 315-341, 1990.
17. M. Kilian, J. Mestecky, and M.W. Russell, Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoblobulin A proteases. Microbiol. Rev., 52: 296-303, 1988.
18. J. Holmgren, J. Clemens, D.A. Sack, J. Sanchez, and A.M. Svennerholm, Oral immunization against cholera. Curr Top. Microbiol. Immunol., 146: 197-204, 1989.
19. F.Y. Liew, S.M. Russell, G. Appleyard, C.M. Brand, and J. Beale, Cross protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol., 14: 350-356, 1984.
20. K. Magnusson and I. Stjernstrom, Mucosal barrier mechanisms: Interplay between secretory IgA (S-IgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunol., 45: 239-248, 1982.
21. M.B. Mazanec, C.L. Coudret, and D.R. Fletcher, Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol., 69: 1339-1343, 1995.
22. E.L. Parr and M.B. Parr, Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol., 71: 8109-8115, 1997.
23. E.L. Parr, J.J. Bozzola, and M.B. Parr, Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: Characterization of the antibody in vaginal mucus. J. Reprod. Immunol., 38:15-30, 1998.
24. G.N. Milligan and D.I. Bernstein, Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virol., 206: 234-241, 1995.
25. M.B. Parr and E.L. Parr, Mucosal immunity in the female and male reproductive tracts. In P.L. Ogra, M.E. Lamm, J.R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock (Eds.), Handbook of Mucosal Immunology, San Diego, CA: Academic Press, Inc., pp. 677-689, 1994.
26. M.B. Parr, G.R. Harriman, and E.L. Parr, Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice. Immunol., 95: 208-213, 1998.
27. M.B. Parr and E.L. Parr, Protective immunity against HSV-2 in the mouse vagina. J. Reprod. Immunol., 36: 77-92, 1997.
28. W.S. Gallichan and K.L. Rosenthal, Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virol., 224: 487-497, 1996.
29. N. Kuklin, M. Daheshia, K. Karem, E. Manickan, and B.T. Rouse, Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol., 71: 3138-3145, 1997.
30. E.L. Parr and M.B. Parr, Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Immunol., 98: 639-645, 1999.
31. M.D. Drew, K.L. Rosenthal, and M.R. McDermott, The design of vaccines for inducing secretory immunity in the reproductive tract. In P.D. Griffin and P.M. Johnson (Eds.), Local Immunity in Reproductive Tract Tissues. Oxford: Oxford University Press, pp. 483-514, 1993.
32. M.B. Parr and E.L. Parr, Immunoglobulins in the female genital tract. In R.A. Bronson, N.J. Alexander, D.J. Anderson, W. Branch, and W.H. Kutteh (Eds.), Reproductive Immunology. Cambridge, MA: Blackwell Scientific, pp. 275-308, 1996.
33. A.M. Eis-Hubinger, D.S. Schmidt, and K.E. Schneweis, Anti-glycoprotein B monoclonal antibody protects T cell depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membrane. J. Gen. Virol., 74: 379-385, 1993.
34. M.E. Ward, The immunobiology and immunopathology of chlamydial infections. APMIS, 103: 769-796, 1995.
35. G.N. Milligan and D.I. Bernstein, Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virol., 212: 481-489, 1995.
36. G.N. Milligan and D.I. Bernstein, Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virol., 229: 259-268, 1997.
37. G.N. Milligan, D.I. Bernstein, and N. Bourne, T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol., 160: 6093-6100, 1998.
38. N.A. Buchmeier and R.D. Schreiber, Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci., 82: 7404-7408, 1985.
39. H. Li, T.R. Jerrells, G.L. Spitalny, and D.H. Walker, Gamma interferon as a crucial host defense against Rickettsia conorri in vivo. Infect. Immun., 55: 1252-1255, 1987.
40. Y. Suzuki, M.A. Orellana, R.D. Schreiber, and J.S. Semington, Interferon-γ: The major mediator of resistance against Toxoplasma gondii. Science, 240: 516-518, 1988.
41. A.J. Ramsay, J. Ruby, and I.A. Ramshaw, A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today, 14: 155-157, 1993.
42. K.E. Squires, R.D. Schreiber, M.J. McElrath, B.Y. Rubin, S.L. Anderson, and H.W. Murray, Experimental visceral leishmaniasis: Role of endogenous IFN-γ in host defense and tissue granulomatous response. J. Immunol., 143: 4244-4249, 1989.
43. G. Zhong, E.M. Peterson, C.W. Czarniecki, R.D. Schreiber, and L.M. de la Maza, Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect. Immun., 57: 152-157, 1989.
44. E.M. Cantin, D.R. Hinton, J. Chen, and H. Openshaw, Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69: 4898-4905, 1995.
45. P.S. Steeg, H.M. Johnson, and J.J. Oppenheim, Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: Inhibitory effect of endotoxin. J. Immunol., 129: 2402, 1982.
46. J.S. Pober, M.A.J. Gimbrone, R.S. Cotran, C.S. Reiss, S.J. Burakoff, W. Fiers, and K.A. Ault, Ia expression by vascular endothelium is inducible by activated T cells and by human γ-interferon. J. Exp. Med., 157: 1339-1351, 1983.
47. T.Y. Basham, B.J. Nickoloff, T.C. Merigan, and V.B. Morhenn, Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes. J. Interferon Res., 5: 23-32, 1985.
48. P. Bland, MHC class II expression by the gut epithelium. Immunol. Today, 9: 174-178, 1988.
49. M.B. Parr and E.L. Parr, The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. (submitted).
50. T.B. Issekutz, J.M. Stoltz, and P.v.d. Meide, Lymphocyte recruitment in delayedtype hypersensitivity. J. Immunol., 140: 2989-2993, 1988.
51. J.M. Munro, J.S. Pober, and R.S. Cotran, Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am. J. Pathol., 135: 121-133, 1989.
52. N. Baumgarth and A. Kelso, In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the focal cellular immune response in lung tissue. J. Virol., 70: 4411-4418, 1996.
53. A. Bot, S. Bot, and C.A. Bona, Protective role of gamma interferon during the recall response to influenza virus. J. Virol., 72: 6637-6645, 1998.
54. A. Billiau, Interferon-γ: Biology and role in pathogenesis. In F.J. Dixon (Ed.), Advances in Immunology. New York: Academic Press, Inc., pp. 61-130, 1996.
55. R. Dijkmans and A. Billiau, Interferon γ: A master key in the immune system. Current Opinion in Immunol., 1: 269-274, 1988.
56. M.A. Farrar and R.D. Schreiber, The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol., 11: 571-611, 1993.
57. C. Nathan, Interferon and inflammation. In J.I. Gallin, I.M. Goldstein, and R. Snyderman (Eds.), Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, pp. 265-290, 1992.
58. T.A. Springer, Traffic signals for lymphocyte recirculation and leukocyte emigration. The multi-step paradigm. Cell 76: 301-314, 1994.
59. M.B. Parr and E.L. Parr, Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunol., 99: 540-545, 2000.
60. N.J.C. King, E.L. Parr, and M.B. Parr, Migration of lymphoid cells from vaginal epithelium to the iliac lymph nodes in relation to vaginal infection by herpes simplex virus type 2. J. Immunol., 160: 1173-1180, 1998.
61. M.B. Parr and E.L. Parr, Immunity to vaginal HSV-2 infection in B cell knockout mice. Immunol., 101: 126-131, 2000.
62. K.L. Dudley, N. Bourne, and G.N. Milligan, Immune protection against HSV-2 in B-cell deficient mice. Virol., 270: 454-463, 2000.
63. N.A. Kuklin, M. Daheshia, S.J. Chun, and B.T. Rouse, Role of mucosal immunity in herpes simplex virus infection. J. Immunol., 160: 5998-6003, 1998.
64. A. Di Tommaso, G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Alrignani, G. Douce, et al., Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun., 64: 974-979, 1996.
65. D.T. O'Hagan, D. Rafferty, J.A. McKeating, and L. Illum, Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein. J. Gen. Viron., 73: 2141-2145, 1992.
66. E.L. Parr and M.B. Parr, Local immunization for antifertility immunity. In D. Griffin and P.M. Johnson (Eds.), Local Immunity in Reproductive Tract Tissues (Scientific Basis of Fertility Regulation). Oxford: Oxford University Press, pp. 441-458, 1993.
67. S. Yang and G. Schumacher, Immune response after vaginal application of antigens in the rhesus monkey. Fertil. Steril., 32: 588-598, 1979.
68. M.B. Parr and E.L. Parr, Female genital tract immunity in animal models. In P.L. Ogra, M.E. Lamm, J.R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock (Eds.), Mucosal Immunology (2nd ed). San Diego: Academic Press, Inc., pp. 1395-1409, 1998.
69. G.L. Ada, Vaccines. In W.E. Paul (Ed.) Fundamental Immunology. New York: Raven Press, pp. 1309-1352, 1993.
70. C.M. Snapper and F.D. Finkelman, Immunologlobulin class switching. In W.E. Paul (Ed.) Fundamental Immunology. New York: Raven Press, pp. 837-864, 1993.